126 related articles for article (PubMed ID: 7144999)
1. Comparison of two molecular species of ethanolamine plasmalogen in multiple sclerosis and normal myelin.
Boggs JM; Stamp D; Moscarello MA
Neurochem Res; 1982 Aug; 7(8):953-64. PubMed ID: 7144999
[TBL] [Abstract][Full Text] [Related]
2. Changes in the composition of two molecular species of ethanolamine plasmalogen in normal human myelin during development.
Boggs JM; Rangaraj G
Biochim Biophys Acta; 1984 Apr; 793(2):313-6. PubMed ID: 6712972
[TBL] [Abstract][Full Text] [Related]
3. A comparison of composition and fluidity of multiple sclerosis and normal myelin.
Boggs JM; Moscarello MA
Neurochem Res; 1980 Mar; 5(3):319-36. PubMed ID: 6246464
[TBL] [Abstract][Full Text] [Related]
4. The stability of myelin ethanolamine glycerophosphatide in post-mortem human and bovine brains.
Fewster ME; Hirono H; Mead JF
J Neurochem; 1972 Jul; 19(7):1803-5. PubMed ID: 5065002
[No Abstract] [Full Text] [Related]
5. EPT1 (selenoprotein I) is critical for the neural development and maintenance of plasmalogen in humans.
Horibata Y; Elpeleg O; Eran A; Hirabayashi Y; Savitzki D; Tal G; Mandel H; Sugimoto H
J Lipid Res; 2018 Jun; 59(6):1015-1026. PubMed ID: 29500230
[TBL] [Abstract][Full Text] [Related]
6. Thin-layer chromatographic resolution of molecular species of ethanolamine plasmalogen quantitatively unique to myelin.
Hack MH; Helmy FM
J Chromatogr; 1977 May; 135(1):229-34. PubMed ID: 67122
[No Abstract] [Full Text] [Related]
7. Phosphatidyl ethanolamine with increased polyunsaturated fatty acids in compensation for plasmalogen defect in the Zellweger syndrome brain.
Saitoh M; Itoh M; Takashima S; Mizuguchi M; Iwamori M
Neurosci Lett; 2009 Jan; 449(3):164-7. PubMed ID: 19013214
[TBL] [Abstract][Full Text] [Related]
8. Preparation of marine plasmalogen and selective identification of molecular species by LC-MS/MS.
Yamashita S; Honjo A; Aruga M; Nakagawa K; Miyazawa T
J Oleo Sci; 2014; 63(5):423-30. PubMed ID: 24717546
[TBL] [Abstract][Full Text] [Related]
9. In vivo characterization of cortical and white matter neuroaxonal pathology in early multiple sclerosis.
Granberg T; Fan Q; Treaba CA; Ouellette R; Herranz E; Mangeat G; Louapre C; Cohen-Adad J; Klawiter EC; Sloane JA; Mainero C
Brain; 2017 Nov; 140(11):2912-2926. PubMed ID: 29053798
[TBL] [Abstract][Full Text] [Related]
10. Influence of Myo-inositol Plus Ethanolamine on Plasmalogens and Cell Viability during Oxidative Stress.
Sibomana I; Grobe N; DelRaso NJ; Reo NV
Chem Res Toxicol; 2019 Feb; 32(2):265-284. PubMed ID: 30604967
[TBL] [Abstract][Full Text] [Related]
11. CSF antibody to myelin basic protein. Measurement in patients with multiple sclerosis and subacute sclerosing panencephalitis.
Panitch HS; Hooper CJ; Johnson KP
Arch Neurol; 1980 Apr; 37(4):206-9. PubMed ID: 6153890
[TBL] [Abstract][Full Text] [Related]
12. Lipid and fatty acid composition of myelin purified from normal and MS brains.
Woelk H; Borri P
Eur Neurol; 1973; 10(4):250-60. PubMed ID: 4778382
[No Abstract] [Full Text] [Related]
13. Brain ethanolamine phospholipids, neuropathology and cognition: A comparative post-mortem analysis of structurally specific plasmalogen and phosphatidyl species.
Goodenowe DB; Senanayake V
Front Cell Dev Biol; 2022; 10():866156. PubMed ID: 36092723
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of phosphatidylethanolamine and ethanolamine plasmalogen by the CDP-ethanolamine and decarboxylase pathways in rat heart, kidney and liver.
Arthur G; Page L
Biochem J; 1991 Jan; 273(Pt 1)(Pt 1):121-5. PubMed ID: 1989575
[TBL] [Abstract][Full Text] [Related]
15. Changes in the amounts of myelin lipids and molecular species of plasmalogen PE in the brain of an autopsy case with D-bifunctional protein deficiency.
Saitoh M; Yamashita S; Shimozawa N; Mizuguchi M; Iwamori M
Neurosci Lett; 2008 Sep; 442(1):4-9. PubMed ID: 18611434
[TBL] [Abstract][Full Text] [Related]
16. Chemical pathology of multiple sclerosis.
Riekkinen PJ; Rinne UK; Arstila AU; Röyttä M
Ann Clin Res; 1973 Oct; 5(5):345-55. PubMed ID: 4134817
[No Abstract] [Full Text] [Related]
17. Abnormal morphology of myelin and axon pathology in murine models of multiple sclerosis.
Bando Y; Nomura T; Bochimoto H; Murakami K; Tanaka T; Watanabe T; Yoshida S
Neurochem Int; 2015 Feb; 81():16-27. PubMed ID: 25595039
[TBL] [Abstract][Full Text] [Related]
18. Alterations of phospholipids, particularly plasmalogens, in the demyelination of multiple sclerosis as compared with that of cerebral oedema.
Yanagihara T; Cumings JN
Brain; 1969 Mar; 92(1):59-70. PubMed ID: 5774032
[No Abstract] [Full Text] [Related]
19. Gas chromatographic determination of the fatty acid pattern of red cell membrane plasmalogens in healthy children.
Rogiers V
J Chromatogr; 1980 Apr; 182(1):27-33. PubMed ID: 7380900
[TBL] [Abstract][Full Text] [Related]
20. MS/MS and LC-MS/MS analysis of choline/ethanolamine plasmalogens via promotion of alkali metal adduct formation.
Otoki Y; Nakagawa K; Kato S; Miyazawa T
J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Nov; 1004():85-92. PubMed ID: 26447938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
